Engineered immune cells take aim at autoimmune diseases

NCT ID NCT07295847

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 4 times

Summary

This early-stage trial tests a new treatment called AZD0120 for adults with three autoimmune diseases: systemic sclerosis, idiopathic inflammatory myopathies, or difficult-to-treat rheumatoid arthritis. AZD0120 is made from a patient's own immune cells, which are modified in a lab to target and attack faulty cells that drive the disease. The main goal is to check the treatment's safety and find the right dose for future studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC INFLAMMATORY MYOPATHIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    NOT_YET_RECRUITING

    Tucson, Arizona, 85719, United States

  • Research Site

    NOT_YET_RECRUITING

    Stanford, California, 94305-5847, United States

  • Research Site

    NOT_YET_RECRUITING

    Chicago, Illinois, 60637, United States

  • Research Site

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Research Site

    NOT_YET_RECRUITING

    St Louis, Missouri, 63110, United States

  • Research Site

    RECRUITING

    New York, New York, 10032, United States

  • Research Site

    NOT_YET_RECRUITING

    Chapel Hill, North Carolina, 27599, United States

  • Research Site

    NOT_YET_RECRUITING

    Seattle, Washington, 98104, United States

  • Research Site

    RECRUITING

    Darlinghurst, 2010, Australia

  • Research Site

    NOT_YET_RECRUITING

    Waratah, 2298, Australia

  • Research Site

    NOT_YET_RECRUITING

    Berlin, 13353, Germany

  • Research Site

    NOT_YET_RECRUITING

    Erlangen, 91054, Germany

  • Research Site

    NOT_YET_RECRUITING

    Hamburg, 20246, Germany

  • Research Site

    NOT_YET_RECRUITING

    Jena, 07747, Germany

  • Research Site

    NOT_YET_RECRUITING

    Mainz, 55131, Germany

  • Research Site

    NOT_YET_RECRUITING

    Würzburg, 97080, Germany

  • Research Site

    NOT_YET_RECRUITING

    Barcelona, 8035, Spain

  • Research Site

    NOT_YET_RECRUITING

    Madrid, 28041, Spain

  • Research Site

    NOT_YET_RECRUITING

    Madrid, 28046, Spain

  • Research Site

    NOT_YET_RECRUITING

    Huddinge, 141 57, Sweden

  • Research Site

    RECRUITING

    Edinburgh, EH4 2XU, United Kingdom

  • Research Site

    NOT_YET_RECRUITING

    London, SE5 9RS, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.